We describe the current understanding of VISTA biology in the context of these potential predictive patterns and provide insights into how VISTA may play a role in regulating antitumor responses in different types of immune tumor microenvironments alone or together with other checkpoint molecules. The gene discussed is VSIR; the disease is neoplasm.